Akorn to Report Fourth Quarter and Full Year 2016 Results
February 06 2017 - 7:30AM
Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic
pharmaceutical company, today announced that it plans to issue a
press release on Wednesday, March 1, 2017 outlining the fourth
quarter and full year 2016 results.
In addition, the Company will host a conference call at 10:00 am
ET on the same day to discuss its fourth quarter and full year 2016
financial results. The dial-in number to access the call is (844)
249-9382 in the U.S. and +1 (270) 823-1530 for international
callers. The conference ID is 62420433. To access the live webcast,
please go to Akorn’s Investor Relations web site at
http://investors.akorn.com.
A webcast replay of the conference call will be available
shortly following the conclusion of the call and will be available
for 90 days following the call. To access the webcast replay,
please go to Akorn’s Investor Relations web site at
http://investors.akorn.com.
About Akorn:
Akorn, Inc. is a specialty generic pharmaceutical company
engaged in the development, manufacture and marketing of
multisource and branded pharmaceuticals. Akorn has manufacturing
facilities located in Decatur, Illinois; Somerset, New Jersey;
Amityville, New York; Hettlingen, Switzerland and Paonta Sahib,
India that manufacture ophthalmic, injectable and specialty sterile
and non-sterile pharmaceuticals. Additional information is
available on Akorn’s website at www.akorn.com.
Investors/Media:
Stephanie Carrington
ICR, Inc.
(646) 277-1282
Stephanie.carrington@icrinc.com
Akorn (NASDAQ:AKRX)
Historical Stock Chart
From Apr 2024 to May 2024
Akorn (NASDAQ:AKRX)
Historical Stock Chart
From May 2023 to May 2024